Bank of America Provides Color on NuVasive, Buy

Bank of America provided color on NuVasive NUVA. In a research report published today, Bank of America stressed its optimism about the company's long-term performance. In the report, Bank of America states, "Our bullish call on NUVA is based on the simple premise that because of its low valuation (2.5x 2011 revs) and concern over the spine market, hitting estimates is all that should be required to drive NUVA towards our $40 price objective." At the moment, Bank of America has a Buy rating and a price target of $40 placed on the company's stock. On Thursday, NuVasive closed the day at $32.83.